BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31221196)

  • 1. A novel method to establish glucocorticoid resistant acute lymphoblastic leukemia cell lines.
    Gu L; Zhang G; Zhang Y
    J Exp Clin Cancer Res; 2019 Jun; 38(1):269. PubMed ID: 31221196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a novel glucocorticoid-resistant human B-cell acute lymphoblastic leukemia cell line, with AMPK, mTOR and fatty acid synthesis pathway inhibition.
    Li Y; Zuo C; Gu L
    Cancer Cell Int; 2021 Nov; 21(1):623. PubMed ID: 34823530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
    Medh RD; Saeed MF; Johnson BH; Thompson EB
    Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
    Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
    Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-apoptotic protein BIM in apoptosis of glucocorticoid-sensitive and -resistant acute lymphoblastic leukemia CEM cells.
    Zhao YN; Guo X; Ma ZG; Gu L; Ge J; Li Q
    Med Oncol; 2011 Dec; 28(4):1609-17. PubMed ID: 20697841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of a distinctive set of genes in glucocorticoid-evoked apoptosis in CEM human lymphoid cells.
    Thompson EB; Johnson BH
    Recent Prog Horm Res; 2003; 58():175-97. PubMed ID: 12795419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anisomycin induces apoptosis of glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells via activation of mitogen-activated protein kinases p38 and JNK.
    Liu Y; Ge J; Li Q; Gu L; Guo X; Ma ZG; Zhu YP
    Neoplasma; 2013; 60(1):101-10. PubMed ID: 23067223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression differences in TEL-AML1 fusion gene in leukemia glucocorticoid-sensitive and -resistant cell lines.
    Wang XW; Xu YH
    Genet Mol Res; 2015 Jul; 14(3):7883-93. PubMed ID: 26214469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Honokiol induces apoptosis and autophagy in dexamethasone-resistant T-acute lymphoblastic leukemia CEM-C1 cells.
    Liu Y; Zhang S; Tan Y
    Hematology; 2024 Dec; 29(1):2337307. PubMed ID: 38573223
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK/JNK.
    Liu Y; Ge J; Li Q; Guo X; Gu L; Ma ZG; Li XH; Zhu YP
    Leuk Lymphoma; 2014 Sep; 55(9):2179-88. PubMed ID: 24597985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of intracellular free Ca(II) and Zn(II) in dexamethasone-induced apoptosis and dexamethasone resistance in human leukemic CEM cell lines.
    Adebodun F; Post JF
    J Cell Physiol; 1995 Apr; 163(1):80-6. PubMed ID: 7896902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells.
    Medh RD; Wang A; Zhou F; Thompson EB
    Oncogene; 2001 Aug; 20(34):4629-39. PubMed ID: 11498786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid-receptor-gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines.
    Hala M; Hartmann BL; Böck G; Geley S; Kofler R
    Int J Cancer; 1996 Nov; 68(5):663-8. PubMed ID: 8938150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.
    Geley S; Hartmann BL; Hala M; Strasser-Wozak EM; Kapelari K; Kofler R
    Cancer Res; 1996 Nov; 56(21):5033-8. PubMed ID: 8895760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PON2 blockade overcomes dexamethasone resistance in acute lymphoblastic leukemia.
    Hui PY; Chen YH; Qin J; Jiang XH
    Hematology; 2022 Dec; 27(1):32-42. PubMed ID: 34957927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.
    Gong H; Liu L; Cui L; Ma H; Shen L
    Mol Carcinog; 2021 Sep; 60(9):644-657. PubMed ID: 34169564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hypoxia on proliferation and glucocorticoid resistance of T-cell acute lymphoblastic leukaemia.
    Li Y; Wei Y; Gu L
    Hematology; 2021 Dec; 26(1):775-784. PubMed ID: 34565306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroid effects on lipid lateral diffusion in CEM-C1 and CEM-C7 acute lymphoblastic leukemia cells.
    Bulva CJ; Printen J; Melnykovych G; Cutts L; Barisas BG; Roess DA
    Biochim Biophys Acta; 1991 Aug; 1094(1):134-7. PubMed ID: 1883851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and characterization of a novel childhood acute lymphoblastic leukemia cell line, HXEX-ALL1, with chromosome 9p and 17p deletions.
    Zhu Y; Yang R; Gao J; Zhang Y; Zhang G; Gu L
    Cancer Cell Int; 2019; 19():113. PubMed ID: 31168295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia.
    Qattan MY; Bakker EY; Rajendran R; Chen DW; Saha V; Liu J; Zeef L; Schwartz JM; Mutti L; Demonacos C; Krstic-Demonacos M
    PLoS One; 2017; 12(6):e0178606. PubMed ID: 28582465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.